EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 100 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $15,340 | -94.3% | 13,000 | -63.4% | 0.00% | -94.7% |
| Q3 2022 | $267,000 | +19.2% | 35,500 | 0.0% | 0.02% | +26.7% |
| Q2 2022 | $224,000 | -24.1% | 35,500 | 0.0% | 0.02% | 0.0% |
| Q1 2022 | $295,000 | +60.3% | 35,500 | 0.0% | 0.02% | +36.4% |
| Q4 2021 | $184,000 | -22.4% | 35,500 | 0.0% | 0.01% | -21.4% |
| Q3 2021 | $237,000 | -21.5% | 35,500 | 0.0% | 0.01% | -26.3% |
| Q2 2021 | $302,000 | +3.4% | 35,500 | +7.6% | 0.02% | -5.0% |
| Q1 2021 | $292,000 | -28.1% | 33,000 | 0.0% | 0.02% | -39.4% |
| Q4 2020 | $406,000 | +50.9% | 33,000 | 0.0% | 0.03% | +6.5% |
| Q3 2020 | $269,000 | – | 33,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |